| Date | Title | Description |
| 08.04.2026 | Jeito Capital Hits Record $1.2 Billion (€1 Billion)1 Close for Jeito II Fund to Drive Breakthrough Therapeutic Innovation for Patients | Jeito Capital (“Jeito”), a global independent private equity fund dedicated to Biopharma, today announces the final closing of its second fund Jeito II, exceeding its target at $1.2 billion (above €1 billion)1,2, and marking a new major mil... |
| 07.04.2026 | Corporate Vision and Trade Confrontation: The Shifting U.S. Economic Narrative | Motorola Solutions CEO Greg Brown earns top honors, lauded for transforming the company into a global public safety and security technology leader. His strategic vision and operational prowess drove exceptional growth and innovation. Meanwh... |
| 06.04.2026 | Biotech Firm Gets a New Leader
New chief chosen | - |
| 06.04.2026 | Motorola Solutions' Greg Brown Is Chief Executive Magazine's 2026 CEO of the Year | Chief Executive magazine announced Motorola Solutions Chairman and CEO Greg Brown as 2026 Chief Executive of the Year, recognizing his leadership in transforming the company into a leading safety and security technology provider and deliver... |
| 03.04.2026 | Declining patent filings show Britain has stopped innovating | There are lots of ways to measure innovation, but if we go by patent filings, it’s a sorry image for the UK, writes Ayushma Maharjan
Britain’s days as the home of the Industrial Revolution are long gone. But many people still cling to the n... |
| 29.03.2026 | Back-up care benefits at work go beyond kids, aging parents as more employers pay for pets | Back-up care benefits companies like Wellthy and Bright Horizons now include pets in their programs, alongside children and elderly family members.
Wellthy first began offering pet back-up care in 2024 and added its “Pet Care Concierge” las... |
| 27.03.2026 | Global Crossroads: Pharma Shifts and Markets Sway | Wall Street navigates intense volatility. Geopolitical tensions from the ongoing Iran conflict drive market swings. Oil prices ease on perceived de-escalation, yet regional attacks persist. Global stocks post fragile gains. Amid this turbul... |
| 27.03.2026 | Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week | Novartis’ acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company’s existing allergy portfolio.
It comes just a week after Novartis announced it is acquiring Synnovation subsidiary Pikavation Thera... |
| 25.03.2026 | 5 Things to Know
U.S.-Iran negotiations, Meta trial verdict, OpenAI shuts Sora and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Happy Wednesday. I spent yesterday evening at a market technicals event and then went to watch the “Hannah Montana 20th Anniversary Special.”... |
| 25.03.2026 | Stocks rise and oil prices ease as Wall Street keeps yo-yoing because of the war with Iran | Getting your Trinity Audio player ready...
By STAN CHOE, AP Business Writer
NEW YORK (AP) — Hopes for a possible end to the war with Iran pushed stocks higher on Wall Street Wednesday, while oil prices eased. Related Articles
Europe’s top c... |
| 25.03.2026 | Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline | Merck will acquire Terns for $53 per share in cash, amounting to an equity value of about $6.7 billion.
This is the third multibillion-dollar acquisition for Merck over the past year as it looks to bulk up its portfolio ahead of its best-se... |
| 24.03.2026 | WuXi Biologics Reports Record 2025 Annual Results | Revenue increased 16.7% YoY to RMB 21.8 billion, and revenue from continuous operations grew over 20% YoY
IFRS gross profit margin expanded to 46.0% (+500 bps YoY); adjusted gross profit margin increased to 48.8% (+340bps)
EBITDA rose 38.1%... |
| 23.03.2026 | Investors eye farming as AI’s latest cash cow | A startup fitting livestock with AI-powered collars is closing in on a $2bn valuation, as investors turn their attention to a less obvious frontier for AI.
New Zealand-based Halter is in talks to raise fresh funding led by Founders Fund, th... |
| 21.03.2026 | Biotech Powerhouse Mestag Therapeutics Secures $40M for Advanced Therapies | Mestag Therapeutics has secured $40 million in new financing. This pushes its total funding past $95 million. The Cambridge-based biotech fuels its Phase 1 STARLYS clinical trial for cancer drug MST-0312. This pivotal trial begins in mid-20... |
| 19.03.2026 | Bambusa Therapeutics Appoints Todd James Chief Financial Officer | - Mr. James brings more than 20 years of biopharmaceutical leadership experience, with deep expertise in capital markets, investor relations, and corporate strategy, serving in senior executive roles at Acceleron Pharma prior to its $11.5 b... |
| 19.03.2026 | Harbour BioMed Appoints Dr. Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 19, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody thera... |
| 19.03.2026 | Moon Rabbit Appoints Loren Levinson EVP, Executive Strategy Director | Leadership addition expands agency's strategy capabilities amid continued growth
NEW YORK, March 19, 2026 /PRNewswire-PRWeb/ -- Moon Rabbit, an independent advertising and marketing agency focused on pharma and healthcare, today announced t... |
| 18.03.2026 | Kelun-Biotech to Present the Final OS Analysis of Sacituzumab Tirumotecan (Sac-TMT) from the OptiTROP-Lung03 Study | CHENGDU, China, March 18, 2026 /PRNewswire/ -- The 2026 European Lung Cancer Congress (ELCC) will be held in Copenhagen, Denmark, from March 25 to 28, 2026 (local time). At this congress, the final OS analysis from the pivotal study (OptiTR... |
| 17.03.2026 | Mestag Therapeutics Raises $40M in Financing | Mestag Therapeutics, a Cambridge, UK-based biotech company harnessing fibroblast immunology to develop treatments for cancer and inflammatory diseases, closed a $40m financing.
Backers includwed SV Health Investors, Johnson & Johnson, t... |
| 13.03.2026 | These stocks will benefit from AI and an aging population, Jefferies says. They also pay dividends | - |
| 12.03.2026 | Nuance Pharma Announces Approval of Ohtuvayre® (ensifentrine) in Hong Kong SAR, China | Approval marks the second regulatory approval outside of the U.S. Food and Drug Administration, further expanding access to COPD patients in select Special Administrative Regions (SARs) in Greater China
SHANGHAI, March 12, 2026 /PRNewswire/... |
| 10.03.2026 | Bright spots in tackling AMRs, but drug-resistance outpaces pharma industry efforts: Report | - |
| 06.03.2026 | Orexo changes the organizational structure and management team to increase focus on development of new products | Orexo changes the organizational structure and management team to increase focus on development of new products
Fri, Mar 06, 2026 15:30 CET Report this content
Uppsala, Sweden – March 6, 2026 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), tod... |
| 02.03.2026 | Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis | SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory dis... |
| 27.02.2026 | AI Drug Discovery: Turbine Secures $25M to Revolutionize Biopharma with Virtual Biology | Turbine, the innovative virtual biology company based in Budapest, just secured $25 million in Series B funding. This significant capital infusion, spearheaded by Interactive Venture Partners and backed by Beiersdorf Venture Capital, accele... |
| 26.02.2026 | Synergis Adept Named to G2's 2026 Best Software Awards as Top-Ranked Engineering Document Management Platform in CAD & PLM | QUAKERTOWN, Pa., Feb. 26, 2026 /PRNewswire/ -- Synergis Software announced that Synergis Adept, its engineering document management platform, has been named to G2's 2026 Best Software Awards, ranking No. 37 in the Best CAD & PLM Softwar... |
| 25.02.2026 | Британская GSK покупает канадскую биотехкомпанию 35Pharma за $950 млн | Компания GSK сообщила в среду, что согласилась выплатить $950 млн наличными за канадскую биотехнологическую компанию 35Pharma, что стало второй крупной сделкой нового генерального директора Люка Мийелса, направленной на ускорение разработки... |
| 24.02.2026 | Turbine Raises $25M in Series B Funding | Turbine, a Budapest, Hungary-based virtual biology company, raised $25M in Series B funding.
The round was led by Interactive Venture Partners with participation from Beiersdorf Venture Capital.
The company intends to use the funds to expan... |
| 24.02.2026 | Turbine: $25 Million Series B Raised For Virtual Biology Platform And Immunology Expansion | Turbine, a virtual biology company focused on AI-powered drug discovery, announced it has raised $25 million in a Series B financing round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors inc... |
| 20.02.2026 | With Trump’s ‘reciprocal’ tariffs struck down, here are the industries still facing higher rates | President Donald Trump’s so-called reciprocal tariffs were deemed unconstitutional by the Supreme Court, but some sector-specific tariffs will remain in place.
The Supreme Court ruling covered IEEPA tariffs, used for national emergencies ou... |
| 18.02.2026 | Exclusive: NHS must keep medicine clawback down or lose investment, says weight-jab boss | The NHS must keep its medicines clawback tax low and predictable or else risk disrupting the rollout of weight-loss drugs in the UK, Novo Nordisk’s UK chief has said.
Sebnem Avsar Tuna, general manager of UK operations for the Ozempic and W... |
| 18.02.2026 | Merck to Leverage Mayo Clinic Platform_Orchestrate for AI-Enabled Drug Discovery | What You Should Know
The Deal: Merck and Mayo Clinic have signed a strategic research agreement to apply AI and multimodal data to drug discovery. This is Mayo Clinic’s first collaboration of this scale with a global biopharma company.
The ... |
| 17.02.2026 | To the shareholders of H. Lundbeck A/S | To the shareholders of H. Lundbeck A/S
Tue, Feb 17, 2026 10:00 CET Report this content NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given of the annual general meeting of H. Lundbeck A/S to be held on: WEDNESDAY, 18 MARCH 2026 AT 10:00... |
| 17.02.2026 | Polymer Factory Sweden AB (publ) Interim Report Q4 2025 | Polymer Factory Sweden AB (publ) Interim Report Q4 2025
Tue, Feb 17, 2026 08:00 CET Report this content
Fourth quarter, October-December 2025
Polymer Factory Launches Sales Hub in the United States in cooperation with Labscoop
Polymer Facto... |
| 10.02.2026 | Calla Lily Clinical Care and Merck announce strategic collaboration to advance intravaginal drug delivery platform | Enhancing patient treatment experience and care with a new self-administered solution for vaginal therapeutics
Versatile platform technology developed from a safe, award-winning, FDA-cleared medical device
Strategic collaboration supporting... |
| 06.02.2026 | PDA Introduces the 2026 Board of Directors and Officers | PDA's diverse Board of Directors brings a diverse set of interests, expertise, and experiences.
BETHESDA, Md., Feb. 6, 2026 /PRNewswire-PRWeb/ -- PDA is excited to introduce the all-volunteer 2026 Board of Directors and Officers following f... |
| 06.02.2026 | Cramer calls this drug maker the ‘greatest growth stock.’ He also names a runner-up | - |
| 04.02.2026 | Experimental cholesterol-lowering pill may offer new option for millions | Getting your Trinity Audio player ready...
By LAURAN NEERGAARD
WASHINGTON (AP) — A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported ... |
| 03.02.2026 | Merck tops quarterly estimates, posts modest 2026 guidance as generic competition looms | Merck reported fourth-quarter earnings and revenue that topped estimates on strong demand for its cancer immunotherapy Keytruda and some newer products.
But Merck posted a modest 2026 outlook that fell short of Wall Street’s expectations, a... |
| 03.02.2026 | 5 Things to Know
The xAI-SpaceX merger, Palantir earnings, China’s frowning horses and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Happy Tuesday. I did my workout studio’s Hyrox-themed class yesterday, which not only left me sore but also with a better understanding of wh... |
| 03.02.2026 | Stocks making the biggest moves premarket: Palantir Technologies, Merck, Pfizer & more | - |
| 02.02.2026 | 5 Things to Know
The metal sell-off, Disney earnings, the ‘Melania’ movie and more in Morning Squawk | This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox.
Good morning. America’s favorite groundhog, Punxsutawney Phil, saw his shadow this morning, meaning we’re in for six more weeks of winter. Af... |
| 02.02.2026 | Investor Joe Terranova likes Merck despite pharmaceutical firm’s move to lower drug price | - |
| 30.01.2026 |
Cramer’s week ahead: Earnings from Eli Lilly, Alphabet and Amazon. Plus, jobs data | Monday - Friday, 6:00 - 7:00 PM ET
CNBC’s Jim Cramer said Friday that the market’s subdued finish to the week could be a good thing ahead of a busy earnings slate.
AMD, Alphabet and Amazon are all set to report quarterly results.
The stock ... |
| 29.01.2026 | Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026" | HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That Will Shape 2026", providing an in-dep... |
| 26.01.2026 | [Opinion] 2026: The Dawn of AI-Driven Drug Development | (Yicai) Jan. 23 -- The next big leap for artificial intelligence in healthcare is no longer in the lab, but in clinical trials -- where drug development succeeds or fails.
For years, the conversation around AI in healthcare has been dominat... |
| 24.01.2026 | Heart Attack Survivor and Social Media Powerhouse Dr. ShantaQuilette Carter-Williams to Take Center Stage at WomenHeart's 2026 Summit | WomenHeart has announced its 2026 Summit taking place February 1-3 at the Hilton Washington DC National Mall, The Wharf. Heart attack and stroke survivor Dr. ShantaQuilette Carter-Williams, a social media powerhouse with millions of followe... |
| 23.01.2026 | NVIDIA и Eli Lilly вложат $1 млрд в ИИ-лабораторию лекарств | NVIDIA и фармацевтический гигант Eli Lilly объявили о создании совместной ИИ-лаборатории с инвестициями до $1 млрд на пять лет. Лаборатория расположится в Сан-Франциско и объединит биологов и химиков Lilly с инженерами NVIDIA для круглосуто... |
| 22.01.2026 | European stocks close higher after Trump’s Greenland ‘deal,’ tariffs retreat | LONDON — European stocks finished higher on Thursday after U.S. President Donald Trump said a “framework” agreement had been reached over Greenland, and called off imposing escalating tariffs on a group of European countries.
The pan-Europe... |
| 20.01.2026 | Another alliance of health care and AI signals why pharma stocks should be back in favor | - |
| 20.01.2026 | Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry | Drug pricing, looming patent cliffs, dealmaking and the first year of the second Trump administration dominated conversations at the annual JPMorgan Healthcare Conference in San Francisco.
Top executives from drugmakers of all sizes met wit... |
| 20.01.2026 | Merck and ChemLex Sign Memorandum of Understanding to Advance Automated Chemistry and Technological Innovation | Strategic collaboration establishes a framework to integrate automated experimentation and advanced chemistry workflows to accelerate research and discovery in Life Science and Electronics
SINGAPORE and SHANGHAI, Jan. 20, 2026 /PRNewswire/ ... |
| 15.01.2026 | Nvidia Expands AI Healthcare Push With Lilly, Thermo Fisher | Image: GoldenDayz/Envato
At this week’s J.P. Morgan Healthcare Conference in San Francisco, Nvidia made a series of announcements focused on leveraging its AI capabilities by partnering with healthcare leaders to tackle key medical challeng... |
| 15.01.2026 | JPM Highlights | WuXi Biologics CEO Dr. Chris Chen: Scaled CRDMO Platform Delivering Sustainable High Growth | Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects
209 new integrated projects in 2025 set a new record, with approximately 50% originating from U.S. clients
Complex m... |
| 12.01.2026 | В медицинском секторе ожидают новый виток крупных M&A-сделок в 2026 году | Участники рынка слияний и поглощений в сфере здравоохранения на этой неделе съезжаются в Сан-Франциско накануне 43-й ежегодной конференции JPMorgan Healthcare Conference, рассчитывая на новую волну мега-слияний в 2026 году, которая по масшт... |
| 12.01.2026 | Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib (LNK01001) in Rheumatoid Arthritis | HANGZHOU, China, SHANGHAI and BOSTON, Jan. 12, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical stage innovative drug development company focused on developing inn... |
| 12.01.2026 | Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion | HSK39004, a novel dual‑target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities
BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticke... |
| 09.01.2026 | A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year | Abivax stock rallied in 2025, far outpacing peers, as the French biotech surprised investors with a stellar data readout in July for its lead asset – an ulcerative colitis medicine.
Now, analysts say the French biotech could be bought by a ... |
| 07.01.2026 | Big Pharma race to snap up biotech assets as $170 billion patent cliff looms | Some of the best-selling drugs in the world are facing a loss of exclusivity in key jurisdictions in the upcoming years in what the sector calls “the patent cliff.”
The need for pharma to top up their pipelines coincides with the broader bi... |
| 05.01.2026 | Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positi... | CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab... |
| 29.12.2025 | The best Dow performer of the year isn’t a tech stock. Why analysts don’t expect a repeat performance | - |
| 29.12.2025 | Senator Endorses Discredited Doctor’s Book On A Chemical He Claims Treats Everything From Autism To Cancer | This story was originally published by ProPublica. Republished under a CC BY-NC-ND 3.0 license.
For years, Sen. Ron Johnson has been spreading conspiracy theories and misinformation about COVID-19 and the safety of vaccines.
He’s promoted d... |
| 23.12.2025 | Business Beyond Boundaries: The future of display technology in 2026 | - |
| 21.12.2025 | Трамп договорился с фармакомпаниями о снижении цен на лекарства для хронических болезней | - |
| 20.12.2025 | US Drug Prices Face Seismic Shift: Pharma Giants Negotiate Deep Cuts | The American healthcare landscape is transforming. US drug prices, long the world's highest, face unprecedented pressure. President Trump drove an aggressive campaign to lower prescription costs. His administration pushed the Most Favored N... |
| 19.12.2025 | Nine of the largest pharma companies ink deals with Trump to lower drug prices | Several of the largest U.S. and European-based drugmakers inked deals with President Donald Trump to voluntarily sell their medications for less, as his administration pushes to link the nation’s drug prices to cheaper ones abroad.
Pfizer, ... |
| 19.12.2025 | Trump announces lower drug price deals with 9 pharmaceutical companies | Getting your Trinity Audio player ready...
By SALLY HO
U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Related Articles
Michael Jackson, Diana Ross and ... |
| 19.12.2025 | Takeda Rises After AI-Developed Psoriasis Pill Trial Success | - |
| 15.12.2025 | Берлинские уговоры | - |
| 12.12.2025 | Болезням прописали инструкцию | - |
| 11.12.2025 | 2025: It’s been one hell of a year for UK business | From political drama to market volatility, cyber attacks, takeovers and trade wars – 2025 has not been plain sailing.
We began the year reporting on the exodus from the London stock exchange noting that 2024 had been the quietest year on re... |
| 10.12.2025 | Lynk Pharmaceuticals and Formation Bio Enter Exclusive Development and Licensing Agreement for LNK01006 | HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio today announced Formation Bio's acquisition of worldwide r... |
| 09.12.2025 | FDA opens safety review of injectable RSV drugs approved for babies and toddlers | Getting your Trinity Audio player ready...
By MATTHEW PERRONE
WASHINGTON (AP) — Food and Drug Administration officials have opened a safety review of two injectable drugs used to protect babies and toddlers from RSV, the respiratory virus t... |
| 01.12.2025 | UK and US agree to zero tariff deal on pharmaceuticals | The government has agreed to a major deal with Washington that will see the UK become the only country to secure zero import tariffs on pharmaceutical products into the US for at least three years.
The deal follows months of negotiations be... |
| 24.11.2025 | Astrazeneca injects $2bn to boost US manufacturing capabilities | FTSE 100 giant Astrazeneca plans to invest $2bn into growing its manufacturing footprint in Maryland, as part of its efforts to boost its US capabilities and presence.
The investment will support the “significant expansion” of its biologics... |
| 24.11.2025 | Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA® (pembrolizumab) as First-Line Treatment for PD-L1-Positive NSCLC Met Primary Endpoint | CHENGDU, China, Nov. 24, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data Monitoring Committee (IDMC) concluded that the Phase III clinical s... |
| 20.11.2025 | Population Health Alliance Awards Merck Culture of Health and Wellbeing Award | Merck announced as the winner of the Population Health Alliance Culture of Health and Wellbeing Award sponsored by HealthNEXT. This award focuses on employers who excel in building cultures of health, safety, and wellbeing and who have lead... |
| 19.11.2025 | SmarterChains on the rise |
One year ago, the Geneva company SmarterChains launched its Manufacturing Value Intelligence platform, with London headquartered DS Smith, one of the world's leading suppliers of corrugated packaging solutions as its 1st Enterprise client.... |
| 18.11.2025 | Американская J&J купит биотех-компанию Halda Therapeutics за $3,05 млрд для разработки препаратов против рака | Компания Johnson & Johnson согласилась приобрести биотехнологическую компанию Halda Therapeutics, разрабатывающую препараты для лечения рака, за $3,05 млрд наличными. Сделка является частью стратегии J&J по компенсации снижения прод... |
| 17.11.2025 | Driving Innovation and Strategic Leadership in Life Sciences: The Career Journey of Ananya Jain | Share
Share
Share
Share
Email
In the fast-evolving world of life sciences, leaders who combine strategic foresight with operational excellence are rare. Among this select group is Ananya Jain, MBA, PMP, a globally recognized portfolio strat... |
| 14.11.2025 | Американская Merck приобретает производителя лекарства от гриппа Cidara Therapeutics за $9,2 млрд | В рамках сделки Merck приобретет все акции Cidara по цене $221,50 за штуку. Совет директоров обеих компаний уже утвердил условия, и завершение ожидается в первом квартале 2026 года после проведения тендерного предложения и получения всех не... |
| 13.11.2025 | Nasdaq closes higher, snapping three-day losing streak as tech stocks recover some ground | The Nasdaq Composite rebounded on Friday as investors bought up shares of key technology stocks a day after the group led Wall Street to its worst day in more than a month.
The tech-heavy Nasdaq gained 0.13% to finish at 22,900.59, snapping... |
| 12.11.2025 | FTSE 100 closes in on 10,000 after outperforming US indices | The FTSE 100 is inching a step closer to the magic 10,000 mark after almost a year of outperforming counterparts across the Atlantic.
London’s blue-chip index rallied on the open before giving up some gains to settle on a broadly flat level... |
| 11.11.2025 | Asia markets mostly rise after Wall Street trades mixed; SoftBank falls as much as 10% after selling entire stake in Nvidia | SoftBank Group shares plunged Wednesday after the company sold its entire stake in U.S. chipmaker Nvidia for $5.83 billion.
Asia-Pacific markets mostly rose.
SoftBank Group shares fell as much as 10% Wednesday after the company said it sold... |
| 11.11.2025 | PDA Releases Three New Foundational Documents to Advance Aseptic Processing and Sterilizing Filtration Practices | These documents reflect PDA's ongoing dedication to providing the pharmaceutical industry with high-quality, practical resources that promote excellence in sterile product manufacturing.
BETHESDA, Md., Nov. 11, 2025 /PRNewswire-PRWeb/ -- Th... |
| 10.11.2025 | Kelun-Biotech Presented TROP2 ADC Sacituzumab Tirumotecan Results From Multiple Clinical Studies at the 2025 CCHIO Congress | CHENGDU, China, Nov. 10, 2025 /PRNewswire/ -- From November 6 to 9, the 2025 Chinese Congress on Holistic Integrative Oncology (CCHIO) was held in Kunming, Yunnan. This conference was jointly organized by the Chinese Anti-Cancer Association... |
| 10.11.2025 | Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate" | 70.6% Partial Response and 82.4% Disease Control Rate Observed in Interim Phase II Data
SEONGNAM, South Korea, Nov. 10, 2025 /PRNewswire/ -- On Friday, 7 November (local time) at the Society for Immunotherapy of Cancer (SITC) 2025 annual me... |
| 08.11.2025 | Accipiter Biosciences Secures $12.7M Seed Funding, Revolutionizing Protein Therapies | Accipiter Biosciences, a Seattle biotech, exited stealth with $12.7 million in seed funding. The company pioneers de novo multifunctional protein therapeutics. Its computational platform designs novel biologics from scratch. These single mo... |
| 07.11.2025 | Accipiter Biosciences: $12.7 Million Seed Funding Closed To Develop De Novo Protein Therapies | Accipiter Biosciences has emerged from stealth with $12.7 million in seed funding to advance a new class of de novo multifunctional protein therapeutics designed to treat complex diseases. The seed round was co-led by Takeda and Flying Fish... |
| 06.11.2025 | Virginia Secures $120 Million Investment To Establish Advanced Pharmaceutical Manufacturing Workforce Center | The Alliance for Building Better Medicine and the Virginia Innovation Partnership Corporation announced that AstraZeneca, Eli Lilly, and Merck will invest $120 million to establish the Virginia Center for Advanced Pharmaceutical Manufacturi... |
| 05.11.2025 | At least seven dead after UPS plane crashes in fireball on takeoff from Kentucky | A UPS wide-body cargo plane crashed on Tuesday (Nov 4) and erupted into a fireball moments after takeoff from the international airport in Louisville, Kentucky, killing seven, including all three aboard, and injuring 11 on the ground, offic... |
| 05.11.2025 | Merck привлечет $700 млн от Blackstone для разработки противораковой терапии | - |
| 05.11.2025 | High energy prices make the UK ‘vulnerable’ US ambassador warns | The US ambassador to the UK has warned Britain’s sky-high energy prices threaten to undermine its status as a major global economy.
Speaking at an event at the Savoy Hotel on Wednesday, Warren Stephens described UK energy prices, which are ... |
| 04.11.2025 | Merck Foundation Unveils $22 Million National Initiative To Advance Equitable Cardiac Care | The Merck Foundation has announced the launch of the Collaborative for Equity in Cardiac Care, a five-year, $22 million initiative aimed at enhancing access to high-quality, person-centered healthcare for individuals living with cardiovascu... |
| 04.11.2025 | Merck Entering $700 Million R&D Funding Agreement With Blackstone Life Sciences | Merck announced that it has entered into a strategic research and development funding agreement with Blackstone Life Sciences for sacituzumab tirumotecan (sac-TMT), an investigational antibody-drug conjugate (ADC) targeting TROP2, a protein... |
| 04.11.2025 | Американская Merck привлекает $700 млн от инвестфонда Blackstone для разработки противораковой терапии | Согласно условиям соглашения, подразделение Blackstone, занимающееся разработкой лекарственных средств, профинансирует часть расходов на проведение испытаний препарата sac-TMT, представляющего собой экспериментальное конъюгированное антител... |
| 03.11.2025 | The Billion-Dollar Biology of Oncology: What Really Drives Pharma’s Appetite? | By Jonathan Tobin, Partner – Brandon Capital
Plenty is written about the trends in dollars and modalities being invested in oncology by VCs. But equally important are the exits, and for early-stage investors M&A is especially important.... |
| 30.10.2025 | Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit | Merck reported third-quarter earnings and revenue that topped estimates in part due to strong demand for its cancer immunotherapy Keytruda, and narrowed its full-year profit outlook to reflect lower estimated tariff costs and other items.
S... |
| 30.10.2025 | Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more | - |
| 29.10.2025 | S&P 500 is dragged down by Meta and Microsoft, but Dow gains as investors rotate out of tech: Live updates | The S&P 500 fell on Thursday as investors digested a batch of Big Tech earnings, while a meeting between President Donald Trump and Chinese President Xi Jinping concluded.
The broad market index dipped 0.3%, while the Nasdaq Composite d... |
